Pulished : October, 2018
ID: 212
Region: Global
Share on

The Global Autoinjectors Market Is Predicted To Reach USD 4.34 Billion By 2022 With A CAGR Of 16.85% According To Market Data Forecast Report.

Pulished: October, 2018
ID: 212
Share on

The Global Autoinjectors Market report published by Market Data Forecast provides a detailed account of the Market Trends via Customized Research presented as Strategic Analyses, Company Profiles, Competitive Landscape, etc. According to the report the Autoinjectors Market is estimated to be USD 1.99 billion in 2017 and predicted to rise to USD 4.34 billion by 2022 with a CAGR of 16.85%. The market is segmented by Product (Fillable Autoinjectors, Prefilled Autoinjectors), Usability (Disposable Autoinjectors, Reusable Autoinjectors), Manufacturing Design (Standardized Autoinjectors, Customized Autoinjectors), Technology (Automated Autoinjectors, Manual Autoinjectors), Application (Anaphylaxis, Multiple Sclerosis, Rheumatoid Arthritis), Distribution Channels (Hospitals, Retail, Online Pharmacies, Others. Further the market is also geographically segmented into North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa.

The major factors driving for the Global Autoinjectors Market are technology advancement and innovation in the drug delivery systems, growing adoption of auto-injectors, rising prevalence of anaphylaxis incidences, diabetes and cancer, simplifying self-medication and improving patient compliance, many advantages like safety, comfort and the accuracy, favorable government policies and high investments by the private companies. However, high price, lack of patient awareness towards self-medication, injuries associated with auto injectors and stringent regulations are hindering the market growth.

Anaphylaxis segment is the largest segment in terms of revenue while Prefilled auto-injectors segment in product type is anticipated to have the highest growth rate.

The market has also been geographically segmented into North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa. North America has the largest market with US has the major contributor in the revenue due to the rising cases of anaphylaxis, increase in disposable income and growth in pharmaceutical industry. However, Asia-Pacific is growing with the fastest rate due to the rising population, increase in chronic diseases and emerging economies like China and India.

Major autoinjector manufacturing companies dominating the market are Mylan N.V., Pfizer, Inc., Bayer AG, Becton, Dickinson and Company, Novartis AG, Biogen Idec, Inc., Janssen Global Services, LLC, Sanofi, Unilife Corporation and Eli Lilly and Company.

Browse through the full report at https://www.marketdataforecast.com/market-reports/autoinjectors-market-6039/ and checkout our recent reports in the Medical Devices at https://www.marketdataforecast.com/subcategory/medical-devices-2/ For more insights and up-to-date industry news don’t forget subscribing to our newsletters.